Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM and GM

24 Jul 2017 11:54

RNS Number : 8992L
Proxama PLC
24 July 2017
 

24 July 2017

 

Proxama Plc

("Proxama" or the "Company")

Result of AGM and GM

Total Voting Rights

Proxama plc (AIM: PROX), the leading mobile proximity marketing expert, is pleased to announce that, at its annual general meeting ("AGM") and subsequent general meeting ("GM") held today all resolutions put forward were duly passed.

Total Voting Rights

Application has been made for the 181,800,000 VCT Placing Shares and 185,701,733 EIS Open Offer Shares to be admitted to trading on AIM, with admission expected to become effective at 08:00 A.M. on 25 July 2017 ("First Admission").

Application has also been made for the 1,000,000,000 Conversion Shares, 4,984,866,667 General Placing Shares and 4,984,047,399 Open Offer Shares to be admitted to trading on AIM, with admission expected to become effective at 08:00 A.M. on 26 July 2017 ("Second Admission").

Following Second Admission, the Company will have 13,745,747,069 Ordinary Shares of 0.01 pence each in issue with each Ordinary Share carrying the right to one vote. There are no Ordinary Shares currently held in treasury. The total number of voting rights in the Company therefore will be 13,745,747,069 and this figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Rules and Transparency Rules.

Directors' participation

The following table sets out the Directors' shareholdings and percentage interests in the issued share capital of the Company following Second Admission, for shares taken up by Directors in both the Placing and Open Offer:

Ordinary Shares Prior to Placing and Open Offer

Participation in the Placing

Immediately following Second Admission

Number of Existing Ordinary Shares

Percentage of issued Existing Ordinary Shares

Number of Placing Shares

Number of Open Offer Shares

Total Number of Ordinary Shares

Percentage of Enlarged Share Capital

Current, Proposed and Past Directors

Kelvin Harrison

(Non- Executive Chairman)

-

-

66,666,666

-

66,666,666

0.48%

John Kennedy

(Chief Executive Officer)

800,000

0.03%

83,333,333

-

84,133,333

0.61%

Shaun Gregory

(Non-Executive Director)

-

-

166,666,666

-

166,666,666

1.21%

Mark Slade

(Managing Director)

-

-

100,000,000

-

100,000,000

0.73%

Dan Francis

(Chief Strategic Officer)

-

-

83,333,333

-

83,333,333

0.61%

David Bailey

(Previous Deputy Chairman)

33,342,125

1.38%

166,666,666

-

200,008,791

1.46%

Total

34,142,125

1.42%

666,666,664

-

700,808,789

5.10%

 

Unless otherwise defined in this announcement, defined terms used have the meaning given to them in the Circular posted to Shareholders on 30 June 2017.

The announcement contains information which, prior to its disclosure, was inside information for the purposes of the Market Abuse Regulation.

Enquiries:

Proxama PLC

John Kennedy

Via Redleaf

Peel Hunt LLP(Nominated Adviser and Broker)

Richard Kauffer/Euan Brown

020 7418 8900

Redleaf Communications

Charlie Geller/Elise Palmer/Sam Modlin

020 7382 4769

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGUSVRRBOABUAR
Date   Source Headline
16th Feb 202412:30 pmRNSResult of General Meeting
6th Feb 202410:55 amRNSHolding(s) in Company
30th Jan 20248:00 amRNSSchedule One - Location Sciences Group Plc
30th Jan 20247:30 amRNSRestoration - Location Sciences Group PLC
30th Jan 20247:00 amRNSAcquisition and Publication of Admission Document
25th Jan 20247:00 amRNSLoan Facility and Holding in Company
20th Dec 20237:00 amRNSFurther update on proposed acquisition of Sorted
6th Oct 20237:00 amRNSUpdate on proposed acquisition of Sorted
14th Sep 20237:00 amRNSHalf-year Report
28th Jul 20231:22 pmRNSResult of AGM
25th Jul 20237:00 amRNSHolding(s) in Company
28th Jun 20237:30 amRNSSuspension - Location Sciences Group plc
28th Jun 20237:00 amRNSLoan Agreement, Proposed Acquisition & Suspension
26th Jun 20237:00 amRNSAnnual Financial Report
11th Apr 20234:56 pmRNSHolding(s) in Company
31st Mar 202311:50 amRNSHolding(s) in Company
27th Mar 20237:00 amRNSHolding(s) in Company
22nd Mar 20233:47 pmRNSHolding(s) in Company
22nd Mar 20231:40 pmRNSHolding(s) in Company
22nd Mar 20239:05 amRNSSecond Price Monitoring Extn
22nd Mar 20239:00 amRNSPrice Monitoring Extension
15th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Sep 20227:00 amRNSHalf-year Report
30th Jun 202211:56 amRNSResult of AGM
6th Jun 20227:00 amRNSNotice of Annual General Meeting
1st Jun 20222:12 pmRNSDirector/PDMR Shareholding
1st Jun 20221:25 pmRNSDirector/PDMR Shareholding
1st Jun 20227:00 amRNSBoard and strategic update
5th Apr 202211:05 amRNSSecond Price Monitoring Extn
5th Apr 202211:00 amRNSPrice Monitoring Extension
30th Mar 20227:00 amRNSAnnual Financial Report
1st Feb 20227:00 amRNSFurther re Sale of Insights dashboard
24th Jan 202211:05 amRNSSecond Price Monitoring Extn
24th Jan 202211:01 amRNSPrice Monitoring Extension
22nd Oct 20218:05 amRNSSale of Insights dashboard
27th Sep 202112:09 pmRNSHalf-year Report
21st Jun 20211:27 pmRNSBusiness Review update and proposed Board changes
21st Jun 202111:28 amRNSHolding(s) in Company
18th Jun 202110:55 amRNSResult of AGM
11th Jun 202110:34 amRNSHolding(s) in Company
8th Jun 202111:54 amRNSHolding(s) in Company
1st Jun 20219:06 amRNSSecond Price Monitoring Extn
1st Jun 20219:00 amRNSPrice Monitoring Extension
28th May 20215:00 pmRNSTotal Voting Rights
28th May 20212:11 pmRNSHolding(s) in Company
27th May 20213:33 pmRNSTR-1 Notification of major holdings
25th May 20218:05 amRNSNotice of AGM
25th May 20218:01 amRNSBoard changes and appointment of Joint Broker
21st May 202111:14 amRNSGM Result, Issue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.